Inactive Instrument
Auspex Pharmaceuticals Inc Stock
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-04-22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 15-04-22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 2009-08-31 |
Rod Ferguson
BRD | Director/Board Member | 69 | 2012-12-31 |
Alex Zisson
BRD | Director/Board Member | 56 | 2013-10-16 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.60% | -10.93% | +45.08% | +60.01% | 68.98B | |
| -4.09% | +3.12% | +3.71% | +53.50% | 53.15B | |
| +0.03% | +7.21% | +12.52% | +44.46% | 50.83B | |
| -1.53% | +3.10% | +31.40% | +33.88% | 44.61B | |
| -5.97% | -5.40% | +259.08% | +494.98% | 40.57B | |
| -1.34% | +5.41% | +16.74% | +106.42% | 42.53B | |
| +6.53% | +8.02% | +18.98% | +54.58% | 30.95B | |
| -0.90% | -10.91% | +34.11% | -1.83% | 25.44B | |
| -2.76% | -4.73% | -15.94% | -15.32% | 22.66B | |
| Average | -1.85% | +1.52% | +45.08% | +92.30% | 42.19B | |
| Weighted average by Cap. | -2.43% | +1.65% | +46.51% | +96.53% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
